🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To compare the impact on recurrence risk of adjuvant Sintilimab (a recombin...
Status
Not Yet Recruiting
Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2023-11-01
Trial ID
NCT06089382
Treatments Being Tested
Ovarian clear cell carcinoma (OCCC) is one of the rare subtypes of ovarian ...
Status
Completed
Location
Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology
Start Date
2021-04-07
Trial ID
NCT04735861
Treatments Being Tested
This study is a single-center, randomized controlled, phase II clinical tri...
Status
Unknown
Location
Multiple Locations
Start Date
2020-03-01
Trial ID
NCT04252365
Treatments Being Tested
To evaluate the efficacy and safety of Anlotinib Hydrochloride in Combinati...
Status
Unknown
Location
Zhejiang Cancer Hospital
Start Date
2020-01-01
Trial ID
NCT04300959
This pilot phase I trial aims to investigate the safety and tolerability of...
Status
Completed
Location
West China Hospital, Sichuan University
Start Date
2019-01-18
Trial ID
NCT03812549
Treatments Being Tested
The purpose of this study is to test the the efficacy and safety of sintili...
Status
Unknown
Location
Zhejiang Cancer Hospital
Start Date
2019-05-01
Trial ID
NCT03940001
Treatments Being Tested
The aim of this study is to explore safety and therapeutic efficacy of anlo...
Status
Unknown
Location
Shanghai Chest Hospital
Start Date
2018-07-20
Trial ID
NCT03628521
Treatments Being Tested
This is phase II study. Efficacy and safety evaluation of IBI308 in patient...
Status
Completed
Location
Jiangsu Provincial Hospital
Start Date
2017-08-23
Trial ID
NCT03228836
Treatments Being Tested
To evaluate the safety and efficacy of HAIC or Lenvatinib combined with Sin...
Status
Active Not Recruiting
Location
Tianjin Medical University Cancer Institute & Hospital
Start Date
2022-12-20
Trial ID
NCT05621499
Treatments Being Tested
This is a phase I/II non-randomized, open-label, single-arm, multicenter st...
Status
Active Not Recruiting
Location
The First Affiliated Hospital of Xiamen University
Start Date
2023-07-19
Trial ID
NCT06220318
Treatments Being Tested